The role of immune checkpoint inhibitors (ICI) in the treatment of metastatic non-small cell lung carcinoma in the elderly

被引：2
|
作者：
Chan, Johan [1 ]
Kanesvaran, Ravindran [1 ]
机构：
[1] Natl Canc Ctr Singapore, 11 Hosp Dr, Singapore 169610, Singapore
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
DECISION-MAKING; POOLED ANALYSIS; OPEN-LABEL; DOCETAXEL; PEMBROLIZUMAB; ATEZOLIZUMAB; CHEMOTHERAPY; MULTICENTER; NIVOLUMAB; AGE;
D O I：
10.21037/atm.2019.12.76
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [22] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [23] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [24] FDA analysis of outcomes in Asian patients (pts) with metastatic non-small cell lung cancer (mNSCLC) receiving immune checkpoint inhibitors (ICI).
    Chang, Elaine
    Gong, Yutao
    Vallejo, Jonathon Joseph
    Liu, Qi
    Mathieu, Luckson Noe
    Booth, Brian
    Sridhara, Rajeshwari
    Beaver, Julia A.
    Pazdur, Richard
    Blumenthal, Gideon Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [26] Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer
    Cunha, R.
    Fernandes, M.
    Abreu, S.
    Oliveira, C.
    Dias, J.
    Alves, S.
    Rodrigues, A.
    Oliveira, J.
    Pousa, M. I.
    Soares, M.
    Azevedo, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [27] Safety of Palliative Radiotherapy and Immune Checkpoint Inhibitors in Patients with Metastatic Non-Small Cell Lung Cancer
    Tjong, M.
    Ragulojan, M.
    Poon, I.
    Cheng, S.
    Doherty, M.
    Ung, Y.
    Cheung, P.
    Cheema, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S667 - S668
  • [28] Efficacy of Re-Treatment with Immune Checkpoint Inhibitors in Patients with Pretreated Advanced Non-Small Cell Lung Carcinoma
    Takahama, T.
    Takeda, M.
    Haratani, K.
    Tanaka, K.
    Hayashi, H.
    Nakagawa, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S933 - S933
  • [29] Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Does Histology Matter?
    Choucair, K.
    Jang, H.
    Jalal, S. I.
    Hadid, T.
    Uprety, D.
    Seongho, K.
    Mamdani, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S613 - S614
  • [30] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC) Treatment: Quo Vadis?
    Gargalionis, Antonios N.
    Papavassiliou, Kostas A.
    Papavassiliou, Athanasios G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
12345